Heron outlines $173M-$183M 2026 net product sales outlook as it targets return to positive adjusted EBITDA
Heron Therapeutics, Inc. · PHARMACEUTICAL PREPARATIONS · Now $0.83
-12% in 7d after detection
Post-detection moves
1h
—
1d
+0.9%
3d
-4.5%
7d
-12%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS